Mellaril and Logorrhea - a phase IV clinical study of FDA data
Summary:
Logorrhea is reported as a side effect among people who take Mellaril (thioridazine hydrochloride), especially for people who are female, 30-39 old, also take Risperdal, and have Pain.
The phase IV clinical study analyzes which people have Logorrhea when taking Mellaril. It is created by eHealthMe based on reports of 1,504 people who have side effects when taking Mellaril from the FDA, and is updated regularly.
What is Mellaril?
Mellaril has active ingredients of thioridazine hydrochloride. eHealthMe is studying from 1,516 Mellaril users. Check the latest studies of Mellaril.
What is Logorrhea?
Logorrhea is found to be associated with 414 drugs and 660 conditions by eHealthMe. Check the latest studies of Logorrhea.
1,504 people reported to have side effects when taking Mellaril.
Among them, 15 people (1.0%) have Logorrhea.

Among these 15 people:
What is the gender of people who have Logorrhea when taking Mellaril? *
- female: 100 %
- male: 0.0 %
What is the age of people who have Logorrhea when taking Mellaril? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 100 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 0.0 %
What are other drugs people take besides Mellaril? *
- Albuterol: 14 people, 93.33%
- Lithium Carbonate: 14 people, 93.33%
- Klonopin: 14 people, 93.33%
- Neurontin: 14 people, 93.33%
- Inderal: 14 people, 93.33%
- Flexeril: 14 people, 93.33%
- Depakote: 14 people, 93.33%
- Clonidine: 14 people, 93.33%
- Remeron: 14 people, 93.33%
- Risperdal: 14 people, 93.33%
What are other side effects people have besides Logorrhea? *
- Agitation (state of anxiety or nervous excitement): 15 people, 100.00%
- Depression: 14 people, 93.33%
- Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 14 people, 93.33%
- Chills (felling of cold): 14 people, 93.33%
- High Blood Pressure: 14 people, 93.33%
- Lymph Follicular Hypertrophy (an increase in the size of the lymph node follicles): 14 people, 93.33%
- Drug Withdrawal Syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation): 14 people, 93.33%
- Respiratory Rate Decreased (less breathing rate/min): 14 people, 93.33%
- Mydriasis (a dilation of the pupil): 14 people, 93.33%
- Sedation: 14 people, 93.33%
What are the existing conditions these people have? *
- Pain: 13 people, 86.67%
* Approximation only. Some reports may have incomplete information.
Do you take Mellaril and have Logorrhea?
- Check whether Logorrhea is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Mellaril:
- Mellaril (1,516 reports)
Logorrhea treatments and more:
- Logorrhea (4,307 reports)
How severe was Logorrhea and when was it recovered:
Expand to all the drugs that have ingredients of thioridazine hydrochloride:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Mellaril:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Logorrhea:
- Logorrhea (415 drugs)
Browse all the conditions that are associated with Logorrhea:
- Logorrhea (660 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on thioridazine hydrochloride (the active ingredients of Mellaril) and Mellaril (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Deltasone cause Abdominal Pain Lower? - 2 seconds ago
- Could Atropine cause Muscle Function Loss? - 2 seconds ago
- Could Neoral cause Ill-Defined Disorder? - 7 seconds ago
- Drug interactions of Esmolol Hydrochloride and Pantoprazole Sodium - 22 seconds ago
- Could Kanjinti cause Dyspnea? - 23 seconds ago
- Could Tenofovir Disoproxil Fumarate cause Nervous System Disorder? - 26 seconds ago
- Could Kaletra cause Hepatitis Aggravated? - 28 seconds ago
- Drug interactions of Ademetionine and Estazolam - 30 seconds ago
- Drug interactions of Levaquin and L-Lysine - 34 seconds ago
- Drug interactions of Fluoxetine Hydrochloride and Tpn - 37 seconds ago